Introducing GemPharmatech's Latest Strains: Unveiling the Future of Innovation
Strain ID | Strain Name | Application |
B6-Tg(hSOD1 G93A,hSOD1) | Genetic humanization, ALS disease | |
FAD4T-hTREM2 | Genetic humanization, Alzheimer's disease | |
B6-hSNCA E46K A53T | Genetic humanization, Parkinson's disease | |
B6-hCD36 | Genetic humanization, neuroinflammation | |
B6-Dmd Del45 | Duchenne muscular dystrophy, 45 exon deletion | |
B6-hDLL4 | Genetic humanization, oncology | |
B6-hCD34 | Genetic humanization, oncology | |
B6-hCEACAM5-Tg | Genetic humanization, oncology | |
B6-hIL18R1/hIL18RAP | Genetic humanization, oncology | |
B6-hCD47/hSIRPA | Genetic humanization, oncology | |
BALB/c-hCD44 | Genetic humanization, oncology | |
BALB/c-hGPC3 | Genetic humanization, oncology | |
BALB/c-hSEMA4D | Genetic humanization, oncology | |
BALB/c-hHSA | Genetic humanization, oncology | |
BALB/c-hTROP2 | Genetic humanization, oncology | |
BALB/c-hCD44v6 | Genetic humanization, oncology | |
BALB/c-hCS1 | Genetic humanization, oncology | |
BALB/c-hLRRC15 | Genetic humanization, oncology | |
BALB/c-hNECTIN-4 | Genetic humanization, oncology | |
BALB/c-hTIGIT/hPVRIG | Genetic humanization, oncology | |
BALB/c-hPD1/hPDL1/hTIGIT/hCD9 | Genetic humanization, oncology | |
BALB/c-hPD1/hPDL1/hCD73/hCD39 | Genetic humanization, oncology | |
BALB/c-hHER2 | Genetic humanization, oncology | |
NCG-hHER2 | Genetic humanization, oncology | |
NOD-Scid-hNKp30 | Genetic humanization, oncology | |
B6-hIGHA1 | Genetic humanization, autoimmune disease | |
BALB/c-hIL1RL1 | Genetic humanization, autoimmune disease | |
BALB/c-hKLRB1 | Genetic humanization, autoimmune disease | |
BALB/c-hIL17A | Genetic humanization, autoimmune disease | |
BALB/c-hIL1β | Genetic humanization, autoimmune disease | |
BALB/c-hTLR8 | Genetic humanization, autoimmune disease | |
BALB/c-hFcgRs/hCD47/hSIRPA | Genetic humanization, Fc end modification for antibody drugs, ADCC effect | |
BALB/c-hCD3EDG/hCD22 | Genetic humanization, CD3 bispecific antibody related | |
BALB/c-hCD73/hCD3EDG | Genetic humanization, CD3 bispecific antibody related | |
BALB/c-hGPRC5D/hCD3EDG | Genetic humanization, CD3 bispecific antibody related | |
BALB/c-hCD3EDG/hBCMA | Genetic humanization, CD3 bispecific antibody related | |
B6-Rosa26-hAGT | Genetic humanization, hypertension | |
B6-H11-hREN | Genetic humanization, hypertension | |
B6-hCD200R1 | Genetic humanization, atherosclerosis research | |
B6-hAPOB-Tg | Genetic humanization, hypercholesteremia and atherogenesis | |
B6-hAPOE-DGAT2-LE1 | Genetic humanization, NASH | |
B6-Myh6-R404Q | Hypertrophic cardiomyopathy | |
B6-Mybpc3-KO | hypertrophic cardiomyopathy or dilated cardiomyopathy | |
B6-Kras-G12D/wt; Lyz2-iCre | Spontaneous lung cancer | |
kras-G12C | Kras-related spontaneous tumors | |
KPS | Spontaneous lung cancer | |
KS | Spontaneous lung cancer |